Neurizon Therapeutics Limited (ASX:NUZ)
0.0960
-0.0020 (-2.04%)
Feb 19, 2026, 4:10 PM AEST
-33.79% (1Y)
| Market Cap | 67.49M +9.7% |
| Revenue (ttm) | 1.54M +82.7% |
| Net Income | -16.59M |
| EPS | -0.03 |
| Shares Out | 688.63M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 113,062 |
| Average Volume | 582,989 |
| Open | 0.1000 |
| Previous Close | 0.0980 |
| Day's Range | 0.0960 - 0.1000 |
| 52-Week Range | 0.0790 - 0.1850 |
| Beta | 1.29 |
| RSI | 54.15 |
| Earnings Date | Feb 26, 2026 |